Edenbridge Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EDENBRIDGE PHARMS, and what generic and branded alternatives to EDENBRIDGE PHARMS drugs are available?
EDENBRIDGE PHARMS has eleven approved drugs.
Summary for Edenbridge Pharms
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 11 |
Drugs and US Patents for Edenbridge Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Edenbridge Pharms | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | bisoprolol fumarate; hydrochlorothiazide | TABLET;ORAL | 212678-001 | Jul 9, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Edenbridge Pharms | ALBENDAZOLE | albendazole | TABLET;ORAL | 211117-001 | May 14, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Edenbridge Pharms | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 203559-004 | Feb 6, 2023 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Edenbridge Pharms | DARTISLA ODT | glycopyrrolate | TABLET, ORALLY DISINTEGRATING;ORAL | 215019-001 | Dec 16, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Edenbridge Pharms | YARGESA | miglustat | CAPSULE;ORAL | 209821-001 | Aug 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
